Correlation Between Mineralys Therapeutics, and SIGA Technologies
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and SIGA Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and SIGA Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and SIGA Technologies, you can compare the effects of market volatilities on Mineralys Therapeutics, and SIGA Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of SIGA Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and SIGA Technologies.
Diversification Opportunities for Mineralys Therapeutics, and SIGA Technologies
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mineralys and SIGA is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and SIGA Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SIGA Technologies and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with SIGA Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SIGA Technologies has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and SIGA Technologies go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and SIGA Technologies
Given the investment horizon of 90 days Mineralys Therapeutics, is expected to generate 2.22 times less return on investment than SIGA Technologies. In addition to that, Mineralys Therapeutics, is 1.01 times more volatile than SIGA Technologies. It trades about 0.01 of its total potential returns per unit of risk. SIGA Technologies is currently generating about 0.02 per unit of volatility. If you would invest 718.00 in SIGA Technologies on August 24, 2024 and sell it today you would lose (70.00) from holding SIGA Technologies or give up 9.75% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 90.93% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. SIGA Technologies
Performance |
| Timeline |
| Mineralys Therapeutics, |
| SIGA Technologies |
Mineralys Therapeutics, and SIGA Technologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and SIGA Technologies
The main advantage of trading using opposite Mineralys Therapeutics, and SIGA Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, SIGA Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SIGA Technologies will offset losses from the drop in SIGA Technologies' long position.| Mineralys Therapeutics, vs. Integrated Drilling Equipment | Mineralys Therapeutics, vs. Xponential Fitness | Mineralys Therapeutics, vs. Lipocine | Mineralys Therapeutics, vs. Delek Drilling |
| SIGA Technologies vs. Elanco Animal Health | SIGA Technologies vs. Esperion Therapeutics | SIGA Technologies vs. Catalent | SIGA Technologies vs. China Pharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |